Skip to content

Drug interactions

Brigatinib + Enzalutamide

Severity: Major

Brigatinib and Enzalutamide: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Enzalutamide reduces brigatinib exposure through enzyme induction. Reduced exposure may compromise control of ALK-positive lung cancer.

What this interaction means in plain words

Brigatinib and Enzalutamide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Brigatinib belongs to Oncology; Enzalutamide belongs to Endocrine.

Evidence level: High

Why it happens

CYP3A4 induction by enzalutamide increases brigatinib clearance.

What to do

Avoid concurrent use. If a strong inducer cannot be avoided, brigatinib labeling advises increasing the dose in stepwise fashion and reducing it again after the inducer is stopped.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brigatinib and Enzalutamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Brigatinib with Enzalutamide?

MediHelp rates the interaction as major. Brigatinib and Enzalutamide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Enzalutamide reduces brigatinib exposure through enzyme induction. Reduced exposure may compromise control of ALK-positive lung cancer.

How serious is the interaction between Brigatinib and Enzalutamide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use. If a strong inducer cannot be avoided, brigatinib labeling advises increasing the dose in stepwise fashion and reducing it again after the inducer is stopped.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in